SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-19-001185
Filing Date
2019-04-18
Accepted
2019-04-18 16:24:23
Documents
9
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 S-8 zk1922954.htm S-8 90077
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 10929
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4802
4 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 229329
5 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 136846
6 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 154332
7 EXHIBIT 99.4 exhibit_99-4.htm EX-99.4 125871
8 image1.jpg GRAPHIC 21314
9 image00002.jpg GRAPHIC 67200
  Complete submission text file 0001178913-19-001185.txt   875328
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230942 | Film No.: 19756174
SIC: 2833 Medicinal Chemicals & Botanical Products